deltatrials
Completed NA INTERVENTIONAL 2-arm NCT00764530

Cementless Alumina-Alumina Total Hip and Hybrid

Keramos Ceramic/Ceramic Total Hip System

Sponsor: Encore Medical, L.P.

Conditions Avascular Necrosis Osteoarthritis Post-traumatic Arthritis Rheumatoid Arthritis
Interventions Alumina/Alumina Standard
Updated 7 times since 2017 Last updated: Jul 26, 2017 Started: Nov 30, 2003 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Avascular Necrosis and Osteoarthritis, this trial is completed. The trial is conducted by Encore Medical, L.P. and has accumulated 7 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshotCompleted~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Sep 2017 — Jun 2018 [monthly]

    Completed NA

    Phase: PHASE3 → NA

▶ Show 2 earlier versions

  1. Feb 2017 — Sep 2017 [monthly]

    Completed PHASE3

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Nov 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Encore Medical, L.P.
Data source: Encore Medical, L.P.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations